Hormone use linked to doubled breast cancer risk study says
A large study from the Women's Health Initiative shows estrogen and progestin hormone pills raise breast cancer risk, peaking while use begins and declining after stopping. Researchers say even short use elevates risk but quitting lowers it, with risk aligned to duration of therapy.
MENTIONED IN THIS ARTICLE
San Antonio
Thomas
Rowan Chliebowski
Harbor-Ucla Medical Center
Los Angeles
Claudine Isaacs
Georgetown University
Lombardi Comprehensive Cancer Center
Women's Health Initiative
Wyeth Pharmaceuticals
George W. Bush
Peter Rawdin
University of Texas M.D. Anderson Cancer Center
Houston
Bush
Ravdin
Also Mentioned on This Page
CT Hee
Fifth Third Bank
53.Com
Fdic.gov
Thor Fitrreserves
FDIC
Kaplan
Althou
Aya
Financ
ABC
Chia Hiiny Morwna Farms
Mira Simeon
Gale
North Olmsted
Lorain Rd
Kaplansfurniture
SUN
Elyria
Broad St
Aed